Company intelligence / Profile preview

2care4 Group

Esbjerg V, South Denmark, Denmark2care4.eu ↗

Ownership: Private
Employees: ~175
Development stage: Other

Overview

2care4 operates as one of the largest suppliers of pharmaceuticals in Scandinavia through parallel importation and has developed several generic medicines since launching its first in 2013. The company focuses on supplying original medicines imported from EU/EEA countries as well as developing its own generic products for the Nordic and German markets. No clinical trial results are reported; business model centers on commercialization rather than drug development pipelines.

Modalities: Small moleculeGeneric pharmaceuticals
Industry: Biotech

Beyond the preview

Go deeper on 2care4 Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2care4 Group.

Explore the full profile